Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Musch

Showing results (1-10 of 237) with videos related to

Pageof 24
Sort By:
JAMA Ophthalmology|October 24, 2018
Anti-VEGF Neovascular Age-Related Macular Degeneration Treatment Adherence Requires Attention and ActionDavid C Musch
Science (New York, N.Y.)|March 29, 2005
Abuse of prisoners at Abu GhraibDavid C Musch
JAMA Ophthalmology|September 16, 2021
Another Insight Into COVID-19-Associated NearsightednessDavid C Musch
JAMA Ophthalmology|December 7, 2013
Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degenerationDavid C Musch
Ophthalmology|December 28, 2014
Should we test for genotype in deciding on age-related eye disease study supplementation?Janet Wittes, David C Musch
The New England Journal of Medicine|July 14, 2022
Evidence for Step Therapy in Diabetic Macular EdemaDavid C Musch, Emily Y Chew
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 17, 2007
Synergeyes versus soft toric lenses: vision-related quality of lifeMichael J Lipson, David C Musch
JAMA Ophthalmology|February 14, 2023
Can We Prevent or Delay the Onset of Myopia?David C Musch, Steven M Archer
JAMA Ophthalmology|July 15, 2021
Patching and Atropine for Severe Amblyopia: Are Both Better Than Patching Alone?David C Musch, John D Baker
JAMA Ophthalmology|March 31, 2022
Clinical Relevance of Myopia Control With Specialized SpectaclesDavid C Musch, Steven M Archer
Pageof 24

Showing results (1-10 of 237) with videos related to

Sort By:
Pageof 24
JAMA Ophthalmology|October 24, 2018
Anti-VEGF Neovascular Age-Related Macular Degeneration Treatment Adherence Requires Attention and ActionDavid C Musch
Science (New York, N.Y.)|March 29, 2005
Abuse of prisoners at Abu GhraibDavid C Musch
JAMA Ophthalmology|September 16, 2021
Another Insight Into COVID-19-Associated NearsightednessDavid C Musch
JAMA Ophthalmology|December 7, 2013
Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degenerationDavid C Musch
Ophthalmology|December 28, 2014
Should we test for genotype in deciding on age-related eye disease study supplementation?Janet Wittes, David C Musch
The New England Journal of Medicine|July 14, 2022
Evidence for Step Therapy in Diabetic Macular EdemaDavid C Musch, Emily Y Chew
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 17, 2007
Synergeyes versus soft toric lenses: vision-related quality of lifeMichael J Lipson, David C Musch
JAMA Ophthalmology|February 14, 2023
Can We Prevent or Delay the Onset of Myopia?David C Musch, Steven M Archer
JAMA Ophthalmology|July 15, 2021
Patching and Atropine for Severe Amblyopia: Are Both Better Than Patching Alone?David C Musch, John D Baker
JAMA Ophthalmology|March 31, 2022
Clinical Relevance of Myopia Control With Specialized SpectaclesDavid C Musch, Steven M Archer
Pageof 24